RESPILLIN

4) • The severity and the site of the infection • The age weight and renal function of the patient: as shown below The duration of therapy should be determined by the type of infection and the response of the patient and should generally be as short as possible.

g. g. 4) Early stage: 500 mg to 1 g every 8 hours up to a maximum of 4g/day in divided doses for 14 days (10 to 21 days) Late stage (systemic involvement): 500 mg to 2 g every 8 hours up to a maximum of 6 g/day in divided doses for 10 to 30 days * Consideration should be given to the official treatment guidelines for each indication Children <40 kg Children may be treated with Amoxicillin capsules, dispersible tablets suspensions or sachets.

Amoxicillin Paediatric Suspension is recommended for children under six months of age. Children weighing 40 kg or more should be prescribed the adult dosage. 4) Early stage: 25 to 50 mg/kg/day in three divided doses for 10 to 21 days Late stage (systemic involvement): 100 mg/kg/day in three divided doses for 10 to 30 days + Consideration should be given to the official treatment guidelines for each indication.

*Twice daily dosing regimens should only be considered when the dose is in the upper range. Elderly No dose adjustment is considered necessary. Renal impairment GFR (ml/min) Adults and children ≥ 40 kg Children < 40 kg # greater than 30 no adjustment necessary no adjustment necessary 10 to 30 maximum 500 mg twice daily 15 mg/kg given twice daily (maximum 500 mg twice daily) less than10 maximum 500 mg/day.

15 mg/kg given as a single daily dose (maximum 500 mg) # In the majority of cases, parenteral therapy is preferred. In patients receiving haemodialysis Amoxicillin may be removed from the circulation by haemodialysis. Haemodialysis Adults and children over 40 kg 500 mg every 24 h Prior to haemodialysis one additional dose of 500 mg should be administered.

In order to restore circulating drug levels, another dose of 500mg should be administered after haemodialysis. Children under 40kg 15 mg/kg/day given as a single daily dose (maximum 500 mg). Prior to haemodialysis one additional dose of 15 mg/kg should be administered.

In order to restore circulating drug levels, another dose of 15 mg/kg should be administered after haemodialysis. In patients receiving peritoneal dialysis Amoxicillin maximum 500 mg/day. 8) Method of administration Amoxicillin Capsules are for oral use.

The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and skin rash. The ADRs derived from clinical studies and post-marketing surveillance with amoxicillin, presented by MedDRA System Organ Class are listed below.

The following terminologies have been used to classify the occurrence of undesirable effects. Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1,000 to <1/100), Rare (≥1/10,000 to <1/1,000) Very rare (<1/10,000), Not known (cannot be estimated from the available data).

4). 4). If any hypersensitivity reaction occurs the treatment should be discontinued (See also Skin and subcutaneous tissue disorders). 4). Convulsions may occur in patients with impaired renal function or in those receiving high doses.

4). 4). Black hairy tongue Not known Drug-induced enterocolitis syndrome Hepatobiliary disorders: Very rare Hepatitis and cholestatic jaundice. Moderate rise in AST and/or ALT. 4) and drug reaction with eosinophilia and systemic symptoms (DRESS).

4 and

8). 3). 8). 8). These reactions are more likely to occur in persons with a history of penicillin hypersensitivity and in atopic individuals. If an allergic reaction occurs, amoxicillin therapy must be discontinued and appropriate alternative therapy instituted.

8). DIES is an allergic reaction with the leading symptom of protracted vomiting (1-4 hours after drug intake) in the absence of allergic skin or respiratory symptoms. Further symptoms could comprise abdominal pain, diarrhoea, hypotension or leucocytosis with neutrophilia.

There have been severe cases including progression to shock. 1). This particularly applies when considering the treatment of patients with urinary tract infections and severe infections of the ear, nose and throat. g. 8). 2). 8). This reaction requires amoxicillin discontinuation and contra-indicates any subsequent administration.

Amoxicillin should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform (erythematous) rash has been associated with this condition following the use of amoxicillin. Patients with lymphatic leukaemia and possibly with HIV infection are particularly prone to developing erythematous rashes with amoxicillin.

Amoxicillin should be discontinued if a skin rash occurs. 8). It results directly from the bactericidal activity of amoxicillin on the causative bacteria of Lyme disease, the spirochaete Borrelia burgdorferi. Patients should be reassured that this is a common and usually self- limiting consequence of antibiotic treatment of Lyme disease.

Overgrowth of non-susceptible organisms Prolonged use may occasionally result in overgrowth of non-susceptible organisms. 8). Therefore, it is important to consider the diagnosis in patients who present with diarrhoea during, or subsequent to, the administration of any antibiotics.

Should antibiotic-associated colitis occur, amoxicillin should immediately be discontinued, a physician consulted and appropriate therapy initiated. Anti-peristaltic medicinal products are contra- indicated in this situation. Prolonged therapy Periodic assessment of organ system functions; including renal, hepatic and haematopoietic function is advisable during prolonged therapy.

1. g. g. a cephalosporin, carbapenem or monobactam).